Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Revance Therapeutics, Inc.PRNewsWire • 01/12/22
Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Revance Therapeutics, Inc. on Their BehalfNewsfile Corp • 01/11/22
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RVNCPRNewsWire • 01/09/22
Kessler Topaz Meltzer & Checker, LLP: February 8, 2022 Deadline Reminder for Revance Therapeutics, Inc. Investors in Securities Fraud Class Action LawsuitNewsfile Corp • 01/08/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important February 8 Deadline in Securities Class Action - RVNCNewsfile Corp • 01/07/22
Thornton Law Firm Reminds Revance Therapeutics (RVNC) Investors of Securities Class Action LawsuitNewsfile Corp • 01/07/22
Investor Action Notice: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 01/07/22
Revance Provides Preliminary Fourth Quarter and Full Year 2021 Financial Results and a Corporate UpdateBusiness Wire • 01/07/22
Investor Action Alert: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 01/06/22
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 01/05/22
RVNC Alert: Thornton Law Firm Reminds Revance Therapeutics Investors of Securities Class Action LawsuitNewsfile Corp • 01/04/22
RVNC Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Revance Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the FirmBusiness Wire • 01/04/22
REVANCE THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Revance Therapeutics, Inc. in the United States District Court for the Northern District of CaPRNewsWire • 01/04/22
Lead Plaintiff Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Revance Therapeutics, Inc.PRNewsWire • 01/03/22
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Revance Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - RVNCPRNewsWire • 01/01/22
Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Revance Therapeutics, Inc.Newsfile Corp • 12/31/21
ALERT: Revance Therapeutics, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - RVNCPRNewsWire • 12/31/21
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Revance Therapeutics, Inc. - RVNCPRNewsWire • 12/31/21
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important February 8 Deadline in Securities Class Action - RVNCNewsfile Corp • 12/30/21
Thornton Law Firm Alerts Revance Therapeutics (RVNC) Investors of Securities Class Action LawsuitNewsfile Corp • 12/28/21
Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Revance Therapeutics, Inc. that A Securities Fraud Class Action Lawsuit Has Been FiledNewsfile Corp • 12/28/21
RVNC INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action FiledNewsfile Corp • 12/27/21
RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeutics, Inc.PRNewsWire • 12/25/21
ROSEN, A TOP RANKED LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important February 8 Deadline in Securities Class Action - RVNCPRNewsWire • 12/24/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Fraud Class ActionNewsfile Corp • 12/21/21
